Fresh analysis reveals that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt traditional lifestyle regimens.
Findings released in a major health publication shows that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing these treatments must be informed of the potential of fast rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain suggests a reversion to starting mass within about 18 months.
Analyzing Treatments
The research, which looked at dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
The team note that individuals who shed pounds through lifestyle changes alone generally see a less rapid creep back—approximately 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Experts propose the way of the drugs is key to understanding the accelerated rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making excessive eating much more probable."
A Chronic Condition?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the likelihood of weight regain, the therapy is often ongoing.
This opinion is reinforced by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," comparing it to managing diseases like hypertension.
User Experiences
Individuals who have come off the jabs describe a powerful resurgence of cravings.
"It was like a trigger activating and I was suddenly starving," recalled an individual.
The struggle is worsened if users have not adopted lasting lifestyle or habit changes during treatment.
Growing Adoption
Figures indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Use is higher among females than males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on ongoing lifestyle support.
